Siglecs: From Biomodulation to Immunotherapy

西格莱克 免疫系统 免疫疗法 免疫学 癌症 医学 生物 内科学
作者
Jia Chen,Yumin Huang,Yafei Wang,Tianlei Sun,Congcong Li,Feng Yuan,Zhenbiao Wu
出处
期刊:Current Protein & Peptide Science [Bentham Science Publishers]
卷期号:27 (2): 163-181 被引量:2
标识
DOI:10.2174/0113892037372672250605183318
摘要

BACKGROUND: Sialic acid-binding immunoglobulin-like lectins (Siglecs) are cell-surface immunological receptors predominantly expressed on immune cells such as monocytes, macrophages, and dendritic cells. They play a crucial role in regulating inflammatory processes in various diseases and serve as immunological checkpoints in cancer. Despite several immune checkpoint inhibitors targeting Siglecs having entered clinical trials, the number of Siglec-targeted immunotherapies remains limited. OBJECTIVE: This review aims to investigate the contributions of Siglecs in human diseases and explore novel therapeutic strategies targeting the Siglec-sialic acid immunological axis. METHODS: The authors systematically searched PubMed, Web of Science, and Google Scholar for publications mainly from 2015-2025, using search terms related to Siglecs, tumors, autoimmune diseases, and specific Siglec subtypes (CD169, Siglec2). Studies were included if they examined Siglecs biology, immunomodulation, or immunotherapeutic potential. Studies not directly relevant to Siglecs function/therapeutics and non-peer-reviewed materials (conference abstracts, editorials) were excluded. Screening was done via titles and abstracts with data referenced from research article results, and eligible articles underwent full-text review for final inclusion. RESULTS: The analysis reveals that Siglecs exhibit dual functions, acting as both activators and inhibitors of immune responses. They are implicated in the pathogenesis of various diseases, including cancer, autoimmune disorders, and viral infections. Several Siglec-targeted immunotherapies are currently in clinical trials, demonstrating their potential in disease management. For instance, Siglec15 and Siglec10 have been identified as potential immune checkpoints in cancer, while Siglec2 and Siglec10 play roles in autoimmune diseases like systemic lupus erythematosus (SLE). CONCLUSION: Siglecs are key immunomodulators that mediate cell-cell and pathogen interactions, playing pivotal roles in human diseases. Further research into their mechanisms and clinical applications is essential to fully harness their therapeutic potential. Targeting Siglecs offers promising avenues for developing novel immunotherapies, particularly in cancer and autoimmune diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
糜厉完成签到,获得积分10
1秒前
蔡莹发布了新的文献求助10
1秒前
北海完成签到,获得积分10
2秒前
wanci的应助被下午茶采纳,获得30
2秒前
LZU_Dai完成签到,获得积分10
3秒前
科研通AI65的应助被obito采纳,获得10
3秒前
3秒前
zzx123完成签到,获得积分20
3秒前
ubless607给南楼小阁主的求助进行了留言
4秒前
4秒前
Akim的应助被光电效应采纳,获得10
4秒前
Angleli完成签到,获得积分10
5秒前
dyy123发布了新的文献求助10
5秒前
一一完成签到,获得积分20
5秒前
5秒前
科研通AI6.3的应助被keyanbutong采纳,获得10
5秒前
boom完成签到,获得积分10
6秒前
zhouhuan完成签到 ,获得积分10
6秒前
健壮的大有完成签到,获得积分10
6秒前
烂漫冰烟完成签到,获得积分10
7秒前
8秒前
liu关闭了liu的文献求助
8秒前
yy发布了新的文献求助10
8秒前
9秒前
9秒前
严xixi完成签到 ,获得积分10
10秒前
10秒前
翟思宇发布了新的文献求助10
10秒前
昏睡的衬衫完成签到,获得积分10
11秒前
黑子完成签到,获得积分10
11秒前
聪明依柔完成签到 ,获得积分10
12秒前
13秒前
candiceli发布了新的文献求助20
13秒前
专注寻菱发布了新的文献求助10
13秒前
宋紫馨完成签到 ,获得积分10
14秒前
ali8ba完成签到,获得积分10
14秒前
三岁放火烧山完成签到,获得积分10
14秒前
dyy123完成签到,获得积分10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182102
求助须知:如何正确求助?哪些是违规求助? 9571775
关于积分的说明 21819723
捐赠科研通 7778500
什么是DOI,文献DOI怎么找? 3433617
关于科研通互助平台的介绍 2557786
邀请新用户注册赠送积分活动 2479651